BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 683244)

  • 1. Does indocyanine green predict lidocaine requirements?
    N Engl J Med; 1978 Sep; 299(12):662-3. PubMed ID: 683244
    [No Abstract]   [Full Text] [Related]  

  • 2. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with antiarrhythmic drugs.
    Goldman P; Ingelfinger JA
    N Engl J Med; 1978 May; 298(21):1193-4. PubMed ID: 651949
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple bolus technique for lidocaine administration in acute ischemic heart disease. II. Treatment of refractory ventricular arrhythmias and the pharmacokinetic significance of severe left ventricular failure.
    Wyman MG; Slaughter RL; Farolino DA; Gore S; Cannom DS; Goldreyer BN; Lalka D
    J Am Coll Cardiol; 1983 Oct; 2(4):764-9. PubMed ID: 6886235
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetic characteristics of lidocaine in patients with circulatory failure].
    Kukes VG; Gneushev ET; Utlinskaia MG; Burian EF; Starodubtsev AK
    Farmakol Toksikol; 1981; 44(4):447-50. PubMed ID: 7286204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple bolus technique for lidocaine administration during the first hours of an acute myocardial infarction.
    Wyman MG; Lalka D; Hammersmith L; Cannom DS; Goldreyer BN
    Am J Cardiol; 1978 Feb; 41(2):313-7. PubMed ID: 623022
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
    Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
    J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine kinetics: relationships between early lidocaine kinetics and indocyanine green clearance.
    Zito RA; Reid PR
    J Clin Pharmacol; 1981; 21(2):100-5. PubMed ID: 7229115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of early lidocaine levels in patients.
    Zito RA; Reid PR; Longstreth JA
    Am Heart J; 1977 Sep; 94(3):292-6. PubMed ID: 888762
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
    Sawyer DR; Ludden TM; Crawford MH
    Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha 1-Acid glycoprotein and plasma lidocaine binding.
    Shand DG
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():27-31. PubMed ID: 6705424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man.
    Thomson PD; Rowland M; Melmon KL
    Am Heart J; 1971 Sep; 82(3):417-21. PubMed ID: 5565429
    [No Abstract]   [Full Text] [Related]  

  • 16. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.
    Thomson PD; Melmon KL; Richardson JA; Cohn K; Steinbrunn W; Cudihee R; Rowland M
    Ann Intern Med; 1973 Apr; 78(4):499-508. PubMed ID: 4694036
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood lidocaine levels and kinetics following high-dose intramuscular administration.
    Zener JC; Kerber RE; Spivack AP; Harrison DC
    Circulation; 1973 May; 47(5):984-8. PubMed ID: 4705587
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics of lidocaine after intramuscular injection in patients with acute myocardial infarction (author's transl)].
    Oltmanns D; Siegers CP
    Z Kardiol; 1979 Mar; 68(3):131-6. PubMed ID: 442753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man.
    Stenson RE; Constantino RT; Harrison DC
    Circulation; 1971 Feb; 43(2):205-11. PubMed ID: 5540706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lidocaine prevention of ventricular fibrillation in acute myocardial infarct at the first-aid and early hospital stages].
    Banshchikov GT; Gudkov GIa; Zinovenko TN; Mazur NA
    Kardiologiia; 1983 May; 23(5):80-2. PubMed ID: 6876554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.